Trial intelligence / Profile preview

Berberine and Bezafibrate in Mixed Dyslipidemia

NCT02548832Phase 3Completed

Sponsor
Universidad de Guadalajara
Start
Apr 2013
Primary completion
Apr 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of berberine in mixed dyslipidemia, sponsored by Universidad de Guadalajara. Started Apr 2013; status: completed.

02

Drugs

berberine
03

Conditions

mixed dyslipidemia

Beyond the preview

Go deeper on NCT02548832.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02548832.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call